Livdelzi 10 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FKJG7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,465
Award facts
- Contract value 100% obligated
- $19,465.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19.5K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Livdelzi 10 mg capsules (30-count units). The award, issued on November 24, 2025, with an ultimate completion date of December 16, 2025, utilizes firm fixed-price pricing with no small business set-aside designation, indicating the company's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR, which was awarded by DLA on November 13, 2025, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
The PPV-G GEN V represents a $30.3 billion acquisition strategy through which DLA established multiple regional prime vendor contractors to supply comprehensive pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's IDC carries a $500M ceiling value with a base period and three option periods extending through December 31, 2036, positioning the company as a critical supplier within the federal pharmaceutical supply chain. The contractor maintains no identified subcontractor relationships and has demonstrated substantial federal contracting activity across diverse therapeutic categories and product lines since its registration in the System for Award Management in July 2001.
Quick answers
Who was awarded contract SPE2DR26FKJG7?
SPE2DR26FKJG7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FKJG7 worth?
The government has obligated $19,465 on SPE2DR26FKJG7.
Is contract SPE2DR26FKJG7 an order under another contract?
Yes. SPE2DR26FKJG7 is a delivery order under SPE2DR25D9105, an indefinite delivery contract.
Was contract SPE2DR26FKJG7 competed?
The extent of competition for SPE2DR26FKJG7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award